Conti F - Search Results

1

NAFLD and liver transplantation: Current burden and expected challenges.

Pais R, Barritt AS 4th, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. Pais R, et al. Among authors: conti f. J Hepatol. 2016 Dec;65(6):1245-1257. doi: 10.1016/j.jhep.2016.07.033. Epub 2016 Jul 30. J Hepatol. 2016. PMID: 27486010 Free PMC article. Review.

2

[Hepatic allograft rejection. Diagnostic and therapeutic aspects].

Calmus Y, Conti F, Dousset B, Houssin D. Calmus Y, et al. Among authors: conti f. Therapie. 1992 Jul-Aug;47(4):265-72. Therapie. 1992. PMID: 1494785 Review. French.

3

Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients.

Conti F, Dousset B, Archambeau D, Louvel A, Houssin D, Calmus Y. Conti F, et al. Transplantation. 1995 Nov 27;60(10):1104-8. doi: 10.1097/00007890-199511270-00008. Transplantation. 1995. PMID: 7482716

4

Quality of life after liver transplantation for cancer.

Boudet MJ, Dousset B, Calmus Y, Conti F, Soubrane O, Houssin D, Chapuis Y. Boudet MJ, et al. Among authors: conti f. Transplant Proc. 1995 Apr;27(2):1796-7. Transplant Proc. 1995. PMID: 7725509 No abstract available.

5

Evidence for the detrimental role of proteolysis during liver preservation in humans.

Calmus Y, Cynober L, Dousset B, Lim SK, Soubrane O, Conti F, Houssin D, Giboudeau J. Calmus Y, et al. Among authors: conti f. Gastroenterology. 1995 May;108(5):1510-6. doi: 10.1016/0016-5085(95)90701-7. Gastroenterology. 1995. PMID: 7729644

6

The influence of cold ischemia time on biliary complications following liver transplantation.

Scotté M, Dousset B, Calmus Y, Conti F, Houssin D, Chapuis Y. Scotté M, et al. Among authors: conti f. J Hepatol. 1994 Sep;21(3):340-6. doi: 10.1016/s0168-8278(05)80311-3. J Hepatol. 1994. PMID: 7836702

7

Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.

Dousset B, Conti F, Houssin D, Calmus Y. Dousset B, et al. Among authors: conti f. N Engl J Med. 1994 Apr 21;330(16):1160-1. doi: 10.1056/NEJM199404213301618. N Engl J Med. 1994. PMID: 8133870 No abstract available.

8

Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.

Conti F, Grude P, Calmus Y, Scoazec JY. Conti F, et al. J Hepatol. 1997 Nov;27(5):881-9. doi: 10.1016/s0168-8278(97)80326-1. J Hepatol. 1997. PMID: 9382976

9

Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.

Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y. Dibo-Cohen JM, et al. Among authors: conti f. Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8. Transplant Proc. 1998. PMID: 9723309 Clinical Trial. No abstract available.

10

Low level of interleukin 10 synthesis during liver allograft rejection.

Conti F, Boulland ML, Leroy-Viard K, Chereau C, Dousset B, Soubrane O, Weill B, Calmus Y. Conti F, et al. Lab Invest. 1998 Oct;78(10):1281-9. Lab Invest. 1998. PMID: 9800954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,517 results

Search Page

Filters